160 Chapter 6 LMIC UMIC HIC Primary (N=630) Secondary or Tertiary (N=1914) Primary (N=506) Secondary or Tertiary (N=2503) Primary (N=921) Secondary or Tertiary (N=4601) Risk factor target attainmentb Smoking target (Never or former smoking) No 148 (23.9) 258 (13.7) 100 (20.4) 576 (23.3) 272 (30.1) 953 (21.1) Yes 470 (76.1) 1625 (86.3) 389 (79.6) 1891 (76.7) 633 (69.9) 3572 (78.9) Missing 12 (1.9) 31 (1.6) 17 (3.4) 36 (1.4) 16 (1.7) 76 (1.7) Physical activity No 252 (40.7) 689 (36.9) 305 (71.8) 1163 (47.7) 369 (58.6) 972 (37.7) Yes 367 (59.3) 1177 (63.1) 120 (28.2) 1277 (52.3) 261 (41.4) 1605 (62.3) Missing 11 (1.7) 48 (2.5) 81 (16.0) 63 (2.5) 291 (31.6) 2024 (44.0) BMI No 290 (57.9) 940 (63.2) 237 (79.0) 1389 (79.5) 440 (75.3) 1796 (76.5) Yes 211 (42.1) 547 (36.8) 63 (21.0) 359 (20.5) 144 (24.7) 551 (23.5) Missing 129 (20.5) 427 (22.3) 206 (40.7) 755 (30.2) 337 (36.6) 2254 (49.0) Waist circumference No 112 (70.9) 263 (74.5) 126 (81.3) 739 (85.7) 290 (91.5) 826 (86.6) Yes 46 (29.1) 90 (25.5) 29 (18.7) 123 (14.3) 27 (8.5) 128 (13.4) Missing 472 (74.9) 1561 (81.6) 351 (69.4) 1641 (65.6) 604 (65.6) 3647 (79.3) Blood pressure No 190 (31.8) 633 (33.9) 198 (46.9) 1025 (43.3) 335 (50.8) 1490 (58.4) Yes 407 (68.2) 1232 (66.1) 224 (53.1) 1340 (56.7) 324 (49.2) 1061 (41.6) Missing 33 (5.2) 49 (2.6) 84 (16.6) 138 (5.5) 262 (28.4) 2050 (44.6) LDL <1.8 mmol/L No 329 (63.9) 847 (51.1) 219 (76.6) 1400 (80.9) 448 (58.0) 2177 (52.6) Yes 186 (36.1) 810 (48.9) 67 (23.4) 330 (19.1) 325 (42.0) 1958 (47.4) Missing 115 (18.3) 257 (13.4) 220 (43.5) 773 (30.9) 148 (16.1) 466 (10.1) LDL <1.4mmol/L No 417 (81.0) 253 (88.5) 1584 (91.6) 592 (76.6) 3177 (76.8) 3177 (76.8) Yes 98 (19.0) 33 (11.5) 146 (8.4) 181 (23.4) 958 (23.2) 958 (23.2) Missing 115 (18.3) 220 (43.5) 773 (30.9) 148 (16.1) 466 (10.1) 466 (10.1) Non-HDL target No 346 (68.0) 226 (84.6) 1337 (85.5) 276 (63.4) 878 (62.4) 878 (62.4) Yes 163 (32.0) 41 (15.4) 227 (14.5) 159 (36.6) 530 (37.6) 530 (37.6) Missing 121 (19.2) 239 (47.2) 939 (37.5) 486 (52.8) 3193 (69.4) 3193 (69.4) Triglycerides No 188 (40.2) 114 (41.9) 696 (38.0) 130 (28.2) 473 (31.0) 473 (31.0) Yes 280 (59.8) 158 (58.1) 1136 (62.0) 331 (71.8) 1051 (69.0) 1051 (69.0) Missing 162 (25.7) 234 (46.2) 671 (26.8) 460 (49.9) 3077 (66.9) 3077 (66.9) Hba1ca No 104 (72.7) 52 (63.4) 247 (65.2) 44 (41.1) 127 (39.7) 127 (39.7) Yes 39 (27.3) 30 (36.6) 132 (34.8) 63 (58.9) 193 (60.3) 193 (60.3) Treatment Antiplatelets No 30 (4.8) 84 (16.6) 297 (11.9) 68 (7.6) 203 (4.7) 203 (4.7) Yes 600 (95.2) 422 (83.4) 2206 (88.1) 825 (92.4) 4097 (95.3) 4097 (95.3) Missing 0 (0) 0 (0) 0 (0) 28 (3.0) 301 (6.5) 301 (6.5) Antihypertensives Supplementary Table 2. Risk factor recording, attainment and treatment by country income group and educational level (%) (continued)
RkJQdWJsaXNoZXIy MTk4NDMw